Global Array Instruments Industry: North America to Continue to Be Market Leader

Array instruments are devices that assist microarrays in measuring the gene expression levels concurrently in a single reaction and also in genotyping various regions of genome. A microarray is a cluster of microscopic spots of RNA, DNA, oligo-nucleotides, peptides, proteins, tissues, cells, and other compounds that are attached to a solid substrate. The concept and methodology of microarray was originally introduced in the year 1983 by Tse Wen Chang in a scientific journal. This traditional biotechnological instrument is gaining acceptance as a rapidly evolving technology.

Download Free Report Brochure For Industry Insight: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=495

The global array market keeps on shifting focus from research and development devices towards various applications in diverse areas such as clinical diagnostics, drug discovery, and sequencing. This technology is majorly applied in cancer detection and treatment, gene expression, SNP genotyping, agricultural biotechnology, genomics, proteomics, and drug discovery. The development in microarray technology assisting in disease detection and drug response are likely to stimulate the growth of the array instruments market. The microarray technology has also been successfully employed in environmental sciences, toxicogneomics, bio-defense, veterinary, agriculture research, and forensics.

The increasing applications of microarrays in life sciences and drug discovery are triggering the demand for microarrays, resulting in the growth of the global market for array instruments. The demand for microarray technology to detect cancer as well as in routine usage is expected to be propelled by the increased rate of production and growth in labeling and diagnosis in near future. Robotics is also playing a key role in laboratory automation to fuel the global array instruments industry.

On the other hand, low acceptance and penetration rate in developing economies owing to the high cost of microarray technology is negatively affecting its usage. Similarly, the introduction of newer technologies is increasing the competition for microarray technology, which is affecting the development of the industry. Also, the lack of effective data analysis tools is likely to restrict the market growth in the near future.

The global array instruments industry reached US$0.87 billion in 2014. It is likely to rise at a CAGR of 4.3% from 2014 and 2020, to reach an expected value of US$1.12 billion by the end of the forecast period.

DNA microarray is the largest market segment according to the technologies employed in the global array instruments industry. The DNA microarray technology held almost 50% of the overall array instruments industry. It is anticipated that the global industry for DNA microarray will expand at a CAGR of 3.9% during the forecast period. In terms of end users, the research and development segment is likely to dominate the global array instruments market during the forecast period.

North America is the leading regional market for array instruments with 50% share of the overall market. The array instruments market in Europe hold the second position occupying almost 30% of the total share. The array instruments market in North America reached a value of US$417.4 million in 2014. It is expected that it will worth US$526.4 million in 2020. The emerging economies in Asia Pacific, Middle East, and Latin America are likely to experience rapid development till 2020. The enhancement in medical and healthcare infrastructure and rising preference for easier and safer targeted therapies are the main factors fueling the growth in these regional markets.

Browse Full Report With TOC:http://www.transparencymarketresearch.com/global-array-market.html

The global array instruments industry is highly fragmented in nature having a number of major and minor players participating in the market. ArrayIt Corporation, Thermo Fisher Scientific, Affymetrix, Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories, Inc., and Illumina, Inc., Molecular Devices, LLC, and Agilent Technologies, Inc. are the prominent players occupying around 80% share of the overall array instruments market. Leading companies are investing heavily in automation of systems that are expected to reap great returns for them in the near future.

About Us:-
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us:-
Mr.Sudip.S
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com

This release was published on openPR.